Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group
Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group
  • The pressure is building for employers, insurers, and Medicare to pay for costly weight-loss drugs.
  • But many health plans aren't yielding and some are making it even harder for folks to get the drugs.
  • Experts say drug prices could drop as more treatments come to market, but it could take years.

If you were hoping that powerhouse weight-loss drugs like Wegovy would be easier to get in 2024, you may be disappointed.